Feng Pan

1.8k total citations
57 papers, 1.2k citations indexed

About

Feng Pan is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Feng Pan has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 13 papers in Surgery and 12 papers in Cancer Research. Recurrent topics in Feng Pan's work include Esophageal Cancer Research and Treatment (9 papers), RNA modifications and cancer (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Feng Pan is often cited by papers focused on Esophageal Cancer Research and Treatment (9 papers), RNA modifications and cancer (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Feng Pan collaborates with scholars based in China, United States and Hong Kong. Feng Pan's co-authors include Wei Gu, Houjie Liang, En‐Min Li, Li‐Yan Xu, Robert H. Singer, Ganfeng Xie, Erhe Gao, Yang Sun, Yanzhen Tan and Jian‐Yi Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Journal of Cell Science.

In The Last Decade

Feng Pan

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Pan China 23 728 323 192 137 105 57 1.2k
Lingyu Luo China 19 776 1.1× 203 0.6× 176 0.9× 132 1.0× 107 1.0× 37 1.3k
Shengbing Liu China 11 798 1.1× 252 0.8× 240 1.3× 80 0.6× 62 0.6× 17 1.4k
Gang Du China 20 759 1.0× 355 1.1× 223 1.2× 120 0.9× 101 1.0× 75 1.5k
Khanh T. Nguyen United States 17 607 0.8× 164 0.5× 200 1.0× 171 1.2× 87 0.8× 40 1.4k
Jungsul Lee South Korea 20 646 0.9× 190 0.6× 204 1.1× 129 0.9× 117 1.1× 54 1.2k
Bao-Wei Wang Taiwan 25 845 1.2× 393 1.2× 150 0.8× 249 1.8× 121 1.2× 47 1.6k
Xiang Lv China 22 1.2k 1.6× 328 1.0× 165 0.9× 73 0.5× 165 1.6× 83 1.8k
Fenglin Zhang China 21 629 0.9× 330 1.0× 137 0.7× 116 0.8× 158 1.5× 62 1.1k
Shuying Dong China 21 633 0.9× 277 0.9× 147 0.8× 78 0.6× 62 0.6× 61 1.2k

Countries citing papers authored by Feng Pan

Since Specialization
Citations

This map shows the geographic impact of Feng Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Pan more than expected).

Fields of papers citing papers by Feng Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Pan. The network helps show where Feng Pan may publish in the future.

Co-authorship network of co-authors of Feng Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Pan. A scholar is included among the top collaborators of Feng Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Pan. Feng Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Weizhong, Chun‐Peng Liu, Yongqiang Zhao, et al.. (2024). Pan-cancer analysis reveals CCL5/CSF2 as potential predictive biomarkers for immune checkpoint inhibitors. Cancer Cell International. 24(1). 311–311. 1 indexed citations
2.
Shi, Wenqi, Ze-Sen Du, Chun‐Peng Liu, et al.. (2024). CD74 is a potential biomarker predicting the response to immune checkpoint blockade. Cancer Cell International. 24(1). 340–340. 1 indexed citations
3.
Zhu, Chunyan, Tian‐Tian Zhai, Meng Su, et al.. (2024). EZH2 elicits CD8+ T-cell desert in esophageal squamous cell carcinoma via suppressing CXCL9 and dendritic cells. Communications Biology. 7(1). 1645–1645. 3 indexed citations
4.
Tan, Xueyun, Feng Pan, Na Zhan, et al.. (2024). Multimodal integration to identify the invasion status of lung adenocarcinoma intraoperatively. iScience. 27(12). 111421–111421. 2 indexed citations
5.
Tan, Yanzhen, Feng Pan, Lei Shi, et al.. (2023). Low‐dose exercise protects the heart against established myocardial infarction via IGF‐1‐upregulated CTRP9 in male mice. SHILAP Revista de lepidopterología. 4(6). e411–e411. 6 indexed citations
6.
Hu, Dan, Xu Hou, Feng Pan, et al.. (2022). Valproate reduces retinal ganglion cell apoptosis in rats after optic nerve crush. Neural Regeneration Research. 18(7). 1607–1607. 5 indexed citations
7.
Yuan, Xianglei, Linjie Guo, Feng Pan, et al.. (2022). Artificial Intelligence for Detecting and Delineating Margins of Early ESCC Under WLI Endoscopy. Clinical and Translational Gastroenterology. 13(1). e00433–e00433. 22 indexed citations
8.
Pan, Feng, Lingli Zhang, Hongjun Luo, et al.. (2020). Dietary riboflavin deficiency induces ariboflavinosis and esophageal epithelial atrophy in association with modification of gut microbiota in rats. European Journal of Nutrition. 60(2). 807–820. 22 indexed citations
9.
Zhang, Bing, Ping Zhang, Yanzhen Tan, et al.. (2019). C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress. Cell Death and Disease. 10(7). 520–520. 57 indexed citations
10.
Zhang, Zhengbin, Yanzhen Tan, Liwen Zhu, et al.. (2019). Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway. Life Sciences. 231. 116554–116554. 65 indexed citations
11.
Zhang, Zhengbin, Liwen Zhu, Feng Pan, et al.. (2019). C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction. Cell Death and Disease. 10(7). 530–530. 25 indexed citations
12.
Zhao, Dajun, Feng Pan, Yang Sun, et al.. (2018). Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis. Cell Death and Disease. 9(7). 723–723. 67 indexed citations
13.
Pan, Feng, Yanxiang Cheng, Haiying Tao, et al.. (2013). Comparison of neuroprotective effect of two postconditioning methods on spinal cord ischemia-reperfusion injury in rats. Zhonghua shiyan waike zazhi. 30(7). 1413–1415. 1 indexed citations
14.
Wu, Feng, Qi Zhou, Guangjie Duan, et al.. (2011). Endogenous Axon Guiding Chemorepulsant Semaphorin-3F Inhibits the Growth and Metastasis of Colorectal Carcinoma. Clinical Cancer Research. 17(9). 2702–2711. 41 indexed citations
15.
Ou, Juanjuan, Feng Pan, Peiliang Geng, et al.. (2011). Silencing Fibronectin Extra Domain A Enhances Radiosensitivity in Nasopharyngeal Carcinomas Involving an FAK/Akt/JNK Pathway. International Journal of Radiation Oncology*Biology*Physics. 82(4). e685–e691. 23 indexed citations
16.
Li, Jianjun, Jian Shen, Jinyan Jiang, et al.. (2011). Multimodal therapy for adult Wilms’ tumour: an experience from one centre. Clinical & Translational Oncology. 13(9). 672–676. 2 indexed citations
17.
Tong, Jingtao, et al.. (2011). Synergistic Antitumor Effect of Dichloroacetate in Combination with 5‐Fluorouracil in Colorectal Cancer. BioMed Research International. 2011(1). 740564–740564. 85 indexed citations
18.
Pan, Feng, et al.. (2010). The Effect of Dexamethasone on the Chemosensitivity of Colon Carcinoma Cells to L-OHP and 5-Fu Treatment. Clinical Oncology and Cancer Research. 37(3). 142–145.
19.
Chang, Pingan, Jianjun Li, Feng Pan, et al.. (2009). Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance. Cancer Science. 100(9). 1708–1713. 20 indexed citations
20.
Zhou, Jinming, et al.. (2008). Downregulation of the Hexokinase II Gene Sensitizes Human Colon Cancer Cells to 5-Fluorouracil. Chemotherapy. 54(5). 357–363. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026